These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34140063)

  • 21. Secondary prevention of stroke in Saskatchewan, Canada: hypertension control.
    Bartsch JA; Teare GF; Neufeld A; Hudema N; Muhajarine N
    Int J Stroke; 2013 Oct; 8 Suppl A100():32-8. PubMed ID: 23088414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
    Kirshner HS
    Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale.
    Casaubon L; McLaughlin P; Webb G; Yeo E; Merker D; Jaigobin C
    Can J Neurol Sci; 2007 Feb; 34(1):74-80. PubMed ID: 17352351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis.
    Sagris D; Georgiopoulos G; Perlepe K; Pateras K; Korompoki E; Makaritsis K; Vemmos K; Milionis H; Ntaios G
    Stroke; 2019 Nov; 50(11):3135-3140. PubMed ID: 31547797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithrombotic therapy in the secondary prevention of stroke].
    Mel'nikova EV; Kadinskaia MI; Gerasimenko DV; Shmonin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):23-7. PubMed ID: 21626814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting.
    Taha A; Nielsen SJ; Franzén S; Rezk M; Ahlsson A; Friberg L; Björck S; Jeppsson A; Bergfeldt L
    J Am Heart Assoc; 2022 May; 11(10):e024703. PubMed ID: 35574947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S; Russo F; Campana C; Agostoni E
    Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
    Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation.
    Arnao V; Agnelli G; Paciaroni M
    Intern Emerg Med; 2015 Aug; 10(5):555-60. PubMed ID: 25862436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Gu HQ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Jiang Y; Li H; Liu C; Xiong YY; Fonarow GC; Wang D; Xian Y; Li ZX; Wang YJ
    JAMA Netw Open; 2021 Jul; 4(7):e2118816. PubMed ID: 34323982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
    Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
    Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preventive treatment to avoid recurrence of stroke and TIA is effective].
    Åsberg S; Redfors P; von Euler M
    Lakartidningen; 2023 Sep; 120():. PubMed ID: 37668114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
    Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
    Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.
    Furie KL; Kasner SE; Adams RJ; Albers GW; Bush RL; Fagan SC; Halperin JL; Johnston SC; Katzan I; Kernan WN; Mitchell PH; Ovbiagele B; Palesch YY; Sacco RL; Schwamm LH; Wassertheil-Smoller S; Turan TN; Wentworth D;
    Stroke; 2011 Jan; 42(1):227-76. PubMed ID: 20966421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA.
    Dia A; Cifu AS; Shah AP
    JAMA; 2021 Jan; 325(1):81-82. PubMed ID: 33399834
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.
    Del Brutto VJ; Chaturvedi S; Diener HC; Romano JG; Sacco RL
    J Am Coll Cardiol; 2019 Aug; 74(6):786-803. PubMed ID: 31395130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.